Btk inhibitor 1,
Btk Inhibitor 1 R-Enantiomer,
1022150-12-4,
1412418-47-3,
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine,
3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
AK161693,
SCHEMBL1614098,
GPSQYTDPBDNDGI-UHFFFAOYSA-N,
BCP08041,
AKOS030526498,
CS-1800,
AC-28741,
HY-13036,
SY114940,
4CH-023207,
MFCD20482137 (95+%),
3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-ami ne,
(R)-4-Amino-3-(4-phenoxyphenyl)-1-(3-piperidyl)-1H-pyrazolo[3,4-d]pyrimidine,
2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl),
Btk inhibitor 1 R enantiomer,
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,